This paper examines the potential roles of mesenchymal stem cells and their exosomes in treating COVID-19. The authors discuss how these therapies may help reduce the harmful inflammation that drives severe disease and support lung tissue recovery.

For patients dealing with long COVID symptoms or post-viral recovery, this research offers important context on regenerative options.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.